Bridget A. Martell - 13 Jun 2023 Form 4 Insider Report for POINT Biopharma Global Inc.

Role: Director
Signature: /s/ William L. Demers, by Power of Attorney for Bridget A. Martell
Issuer symbol: N/A
Transactions as of: 13 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 14 Jun 2023, 18:15:29 UTC
Previous filing: 14 Jun 2023
Next filing: 21 Jul 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PNT	Stock Option (Right to Buy)	Award	$0	+80,503		$0.000000	80,503	13 Jun 2023	Common Stock	80,503	$10.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option will vest 100% on the first anniversary of the grant date.